Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-22-033847)

Filing Details

Accession Number:: 0001209191-22-033847
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-06-03 11:52:43
Reporting Period:: 2022-05-27

Accepted Time:: 2022-06-03 11:52:43
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
822370	Emmaus Life Sciences Inc.	EMMA	Pharmaceutical Preparations (2834)	870419387

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1517775	C Willis Lee	21250 Hawthorne Blvd. Suite 800 Torrance CA 90503	Director & Coo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value	Acquisiton	2022-05-27	2,500	$0.37	281,274	No	4	P	Direct
Common Stock, $0.001 Par Value	Acquisiton	2022-05-31	2,500	$0.40	283,774	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value	241,194	Indirect	By Fidelity Traditional IRA FBO Willis C. Lee
Common Stock, $0.001 Par Value	1,900	Indirect	By Fidelity Roth IRA FBO Willis C. Lee